CoChat

Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots

Open access

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Background: Snakebite in India results in over 58,000 fatalities and a vast number of morbidities annually. The majority of these clinically severe envenomings are attributed to Russell’s viper (Daboia russelii), which has a near pan-India distribution. Unfortunately, despite its medical significance, the influence of biogeography on the composition and potency of venom from disparate D. russelii populations, and the repercussions of venom variation on the neutralisation efficacy of marketed Indian antivenoms, remain elusive. Methods: Here, we employ an integrative approach comprising proteomic characterisation, biochemical analyses, pharmacological assessment, and venom toxicity profiling to elucidate the influence of varying ecology and environment on the pan-Indian populations of D. russelii. We then conducted in vitro venom recognition experiments and in vivo neutralisation assays to evaluate the efficacy of the commercial Indian antivenoms against the geographically disparate D. russelii populations. Findings: We reveal significant intraspecific variation in the composition, biochemical and pharmacological activities and potencies of D. russelii venoms sourced from five distinct biogeographic zones across India. Contrary to our understanding of the consequences of venom variation on the effectiveness of snakebite therapy, commercial antivenom exhibited surprisingly similar neutralisation potencies against the majority of the investigated populations, with the exception of low preclinical efficacy against the semi-arid population from northern India. However, the ability of Indian antivenoms to counter the severe morbid effects of Daboia envenoming remains to be evaluated. Conclusion: The concerning lack of antivenom efficacy against the north Indian population of D. russelii, as well as against two other ‘big four’ snake species in nearby locations, underscores the pressing need to develop pan-India effective antivenoms with improved efficacy in high snakebite burden locales.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pntd.0009247

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Map of India, prepared with QGIS 3.8.2 [35], depicts (A) sampling locations and (B) SDS-PAGE profiles of D. russelii venoms. M: Protein marker (units in kDa); PB: Punjab; TN: Tamil Nadu; AP: Andhra Pradesh; WB: West Bengal; MH: Maharashtra; MP: Madhya Pradesh.
Fig 1 Map of India, prepared with QGIS 3.8.2 [35], depicts (A) sampling locations and (B) SDS-PAGE profiles of D. russelii venoms. M: Protein marker (units in kDa); PB: Punjab; TN: Tamil Nadu; AP: Andhra Pradesh; WB: West Bengal; MH: Maharashtra; MP: Madhya Pradesh.CC BY · PubMed Central
Fig 2 Venom variability in pan-Indian D. russelii populations. This figure depicts RP-HPLC profiles of D. russelii venoms sourced from distinct biogeographic zones. Venom profiles, shown here, highlight the considerable differences in the protein compositions of geographically distinct populations. The area under the curve for all labelled and uniquely colour coded fraction peaks are depicted in the corresponding doughnut charts.
Fig 2 Venom variability in pan-Indian D. russelii populations. This figure depicts RP-HPLC profiles of D. russelii venoms sourced from distinct biogeographic zones. Venom profiles, shown here, highlight the considerable differences in the protein compositions of geographically distinct populations. The area under the curve for all labelled and uniquely colour coded fraction peaks are depicted in the corresponding doughnut charts.CC BY · PubMed Central
Fig 3 Comparative venom profiles of the biogeographically disparate D. russelii populations. This figure represents the relative composition of various toxins constituting D. russelii venoms, as estimated from the mass spectrometry and HPLC data. Each toxin type is uniquely colour coded, and its relative abundance is indicated.
Fig 3 Comparative venom profiles of the biogeographically disparate D. russelii populations. This figure represents the relative composition of various toxins constituting D. russelii venoms, as estimated from the mass spectrometry and HPLC data. Each toxin type is uniquely colour coded, and its relative abundance is indicated.CC BY · PubMed Central
Fig 4 Coagulopathies induced by the biogeographically distinct populations of D. russelii. Heatmaps depict the influence of D. russelii venoms in impeding the (A) extrinsic and (B) intrinsic blood coagulation pathways, respectively. (C) The impact of varying concentrations of venoms (15.6 to 250 ng) on plasma clotting time (mins), and the ability of Premium Serums antivenom (1:4 dilution of 1 mg/ml or 0.25 μg/μl antivenom) in neutralising these effects are shown as bar graphs. The error bars represent the standard deviation among the replicates. (D) Haemolytic activities of D. russelii venoms have also been shown. Numbers inside each tile in A and B denote the plasma clotting time in seconds, and the numbers in D indicate the percentage of relative activity with respect to the positive control (0.5% Triton X). Blank: plasma control; ASV Blank: plasma + antivenom (1:4); NC: negative control; PB: Punjab; TN: Tamil Nadu; AP: Andhra Pradesh; WB: West Bengal; MH: Maharashtra; MP: Madhya Pradesh.
Fig 4 Coagulopathies induced by the biogeographically distinct populations of D. russelii. Heatmaps depict the influence of D. russelii venoms in impeding the (A) extrinsic and (B) intrinsic blood coagulation pathways, respectively. (C) The impact of varying concentrations of venoms (15.6 to 250 ng) on plasma clotting time (mins), and the ability of Premium Serums antivenom (1:4 dilution of 1 mg/ml or 0.25 μg/μl antivenom) in neutralising these effects are shown as bar graphs. The error bars represent the standard deviation among the replicates. (D) Haemolytic activities of D. russelii venoms have also been shown. Numbers inside each tile in A and B denote the plasma clotting time in seconds, and the numbers in D indicate the percentage of relative activity with respect to the positive control (0.5% Triton X). Blank: plasma control; ASV Blank: plasma + antivenom (1:4); NC: negative control; PB: Punjab; TN: Tamil Nadu; AP: Andhra Pradesh; WB: West Bengal; MH: Maharashtra; MP: Madhya Pradesh.CC BY · PubMed Central
Fig 5 Immunological cross-reactivity of commercial Indian antivenoms against the pan-Indian populations of D. russelii venoms. Heatmaps, shown here, quantify the binding of commercial Indian antivenoms to the venoms of pan-Indian populations of D. russelii. Multiple dilutions of antivenoms (1:500, 1:2500 and 1:12500) were tested in indirect ELISA experiments. Non-specific binding of naive horse IgGs (1:4 dilution) to Daboia venoms is also shown in the first plate for reference. A gradient colour scale has been shown indicating the degree of binding from low (black) to high (cream). PB: Punjab; TN: Tamil Nadu; AP: Andhra Pradesh; WB: West Bengal; and MH: Maharashtra; MP: Madhya Pradesh.
Fig 5 Immunological cross-reactivity of commercial Indian antivenoms against the pan-Indian populations of D. russelii venoms. Heatmaps, shown here, quantify the binding of commercial Indian antivenoms to the venoms of pan-Indian populations of D. russelii. Multiple dilutions of antivenoms (1:500, 1:2500 and 1:12500) were tested in indirect ELISA experiments. Non-specific binding of naive horse IgGs (1:4 dilution) to Daboia venoms is also shown in the first plate for reference. A gradient colour scale has been shown indicating the degree of binding from low (black) to high (cream). PB: Punjab; TN: Tamil Nadu; AP: Andhra Pradesh; WB: West Bengal; and MH: Maharashtra; MP: Madhya Pradesh.CC BY · PubMed Central
Fig 6 Venom potencies of the pan-Indian populations of D. russelii and the neutralisation potencies of the Premium Serums antivenom. This figure depicts (A) venom potencies (mg/kg) of various D. russelii populations and (B) the neutralising potencies (mg/ml) of the Premium Serums antivenom against them. The error bars show 95% confidence intervals, and the marketed neutralising potency (0.60 mg/ml) of the commercial product against D. russelii venom is shown as a vertical dotted line (panel B).
Fig 6 Venom potencies of the pan-Indian populations of D. russelii and the neutralisation potencies of the Premium Serums antivenom. This figure depicts (A) venom potencies (mg/kg) of various D. russelii populations and (B) the neutralising potencies (mg/ml) of the Premium Serums antivenom against them. The error bars show 95% confidence intervals, and the marketed neutralising potency (0.60 mg/ml) of the commercial product against D. russelii venom is shown as a vertical dotted line (panel B).CC BY · PubMed Central
Fig 7 The preclinical inefficacy of Indian antivenom therapy in snakebite hotspots. This figure depicts the alarming preclinical ineffectiveness of commercial antivenoms in the major snakebite hotspots of India (highlighted in red circles). The relative differences in neutralisation potencies of antivenoms against the geographically distinct populations of N. naja (green vials) [71], D. russelii (yellow vials) and B. caeruleus (purple vial) [20] are shown in comparison to the venom source (for antivenom production) population in southern India. The red dotted lines on vials represent the marketed neutralising potency of the commercial products. Sampling locations have been indicated with uniquely coloured markers (top right box) on the biogeographical map of India that was prepared with QGIS 3.8.2 [35]. The intensity of purple clouds on the map is indicative of the estimated standardised snakebite death rates per million reported by Suraweera et al. 2020 [2], with the brighter regions representing the major hotspots.
Fig 7 The preclinical inefficacy of Indian antivenom therapy in snakebite hotspots. This figure depicts the alarming preclinical ineffectiveness of commercial antivenoms in the major snakebite hotspots of India (highlighted in red circles). The relative differences in neutralisation potencies of antivenoms against the geographically distinct populations of N. naja (green vials) [71], D. russelii (yellow vials) and B. caeruleus (purple vial) [20] are shown in comparison to the venom source (for antivenom production) population in southern India. The red dotted lines on vials represent the marketed neutralising potency of the commercial products. Sampling locations have been indicated with uniquely coloured markers (top right box) on the biogeographical map of India that was prepared with QGIS 3.8.2 [35]. The intensity of purple clouds on the map is indicative of the estimated standardised snakebite death rates per million reported by Suraweera et al. 2020 [2], with the brighter regions representing the major hotspots.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Research works printed but not linked: 1

  1. D Finney, 1971, Probit Analysis

Cited by

See all 101

Metadata

Authors
Senji Laxme, R. R., Khochare, S., Attarde, S., Suranse, V., Iyer, A., Casewell, N. R., Whitaker, R., Martin, G., & Sunagar, K.
Affiliations
  • Indian Institute of Science Bangalore (IN)
  • Liverpool School of Tropical Medicine (GB)
Corresponding author
Sunagar, Kartik
Venue
PLOS Neglected Tropical Diseases
Published
2021-03-25
Volume
15
Issue
3
Pages
e0009247
ISSN
  • 1935-2727 (ISSN-L)
  • 1935-2735
OpenAlex
W3136692657
Cited by
101
References
79
Citations by year
2026: 19 · 2025: 19 · 2024: 23 · 2023: 18 · 2022: 10 · 2021: 12
FWCI
8.91
Type
journal article
Language
en
Open access
Locations
  • PLoS neglected tropical diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NOT FOUND REPOSITORY (Indian Institute of Science Bangalore) (acceptedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Department for International Development, UK Government (IAVI/BES/KASU/0002)
  • Department of Biotechnology, India (DBT-IISc Partnership Program)
  • Department of Science and Technology, India (DST-FIST (SR/FST/LS-II/2018/233), DST-INSPIRE Faculty Award (DST/INSPIRE/04/2017/000071))
  • Wellcome Trust and Royal Society (Sir Henry Dale Fellowship (200517/Z/16/Z))
  • USV Private Limited (Venom sampling equipment and expeditions)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Venomous Animal Envenomation and Studies
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Amphibian and Reptile Biology
  • Health Sciences › Medicine › Pharmacology (medical) › Healthcare and Venom Research
Keywords
Russell's viper, Daboia russelii, snakebite, venom variation, biogeography, antivenom efficacy, venom proteomics, intraspecific venom variation
MeSH terms
Animals, Antivenins, India, Male, Snake Bites, Viper Venoms, Ecosystem, Daboia, Proteome, Reptilian Proteins, Mice, Tandem Mass Spectrometry, Phylogeography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots. https://app.cochat.ai/papers/10.1371/journal.pntd.0009247
The paper
Senji Laxme, R. R., Khochare, S., Attarde, S., Suranse, V., Iyer, A., Casewell, N. R., Whitaker, R., Martin, G., & Sunagar, K. (2021). Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0009247

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.